[Polymyositis].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D003882:Dermatomyositis / Q000209:etiology; D004798:Enzymes / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy; D008727:Methotrexate / Q000627:therapeutic use; D009129:Muscle Tonus; D009133:Muscular Atrophy / Q000209:etiology; D009220:Myositis / Q000145:classification; D009369:Neoplasms / Q000150:complications; D010146:Pain / Q000209:etiology; D010243:Paralysis / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004798:Enzymes; D011241:Prednisone; D008727:Methotrexate
Polymyositiden.